ResMed Announces Participation in the William Blair 41st Annual Growth Stock Conference
ResMed (NYSE: RMD) announced that Rob Douglas, president and COO, will participate in a virtual fireside chat at the William Blair 41st Annual Growth Stock Conference on June 1, 2021, at 1:20 p.m. CDT. The event will be accessible via video webcast, with a replay available approximately 24 hours after the event and lasting until July 1, 2021. ResMed focuses on innovative solutions for chronic diseases, helping improve patient quality of life and reduce healthcare costs worldwide.
- Participation in a major investor conference may enhance market visibility.
- The company is actively engaging with investors, indicating transparency and openness.
- ResMed continues to showcase its commitment to innovation and chronic disease management.
- None.
SAN DIEGO, May 25, 2021 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Rob Douglas, president and chief operating officer, will participate in a virtual fireside chat at the William Blair 41st Annual Growth Stock Conference on Tuesday, June 1, 2021, beginning at approximately 1:20 p.m. (Central Daylight Time) via video webcast.
More information about this event, including access to the live webcast, may be accessed by visiting http://investor.resmed.com. The webcast replay will be available approximately 24 hours after the live webcast ends and will be accessible through July 1, 2021.
About ResMed
At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries. To learn more, visit ResMed.com and follow @ResMed.
For investors | For media |
Amy Wakeham | Jayme Rubenstein |
+1 858.836.5000 | +1 858.836.6798 |
investorrelations@resmed.com | news@resmed.com |
FAQ
When is ResMed's fireside chat at the William Blair conference?
Who will represent ResMed at the William Blair conference?
How can I access the ResMed conference webcast?
What is ResMed's focus in the healthcare market?